Tue, 24 November 2020
In this episode, Hall welcomes David Bach, MD, CEO and Founder of Optios.
Optios is a leader in the rapidly-emerging neuro-performance industry. Based on more than a decade of work at DARPA, hundreds-of-millions of dollars of proprietary research, and close partnerships with the world's most elite organizations, Optios' guiding mission is to build an intellectual framework and platform that supports the next phase in human development. Neuroscience is the next frontier in management. Optimizing leaders' brains will soon be a critical source of competitive advantage in the business world.
Today, due to recent neuroscience advances, they (Optios) can rewire the human brain in targeted ways that profoundly enhance human performance, cognition, creative capacity, learning speed, health, and even longevity.
David Bach, MD is a Harvard-trained scientist and Founder and CEO of Optios. Prior to founding Optios, David was a serial entrepreneur, venture capitalist, management consultant, scientist, physician, martial artist, and professional cellist. As an entrepreneur, he founded and built three prior companies: Touchstone Health, Empyrean Benefit Solutions, and Leprechaun HCC Management. Each of these became a $200M+ enterprise. His venture capital experience was with TA Associates in Boston.
After spending a decade maximizing his physical and mental performance, David created Optios to bring scientific rigor to, and create commercial applications in, the rapidly-expanding arena of applied neuroscience.
David attended Harvard College and Harvard Medical School. His scientific training was at The Dana-Farber Cancer Institute.
In this interview, David shares with Hall what led him to start working in the neuro-performance space and delves a bit into the science behind Optios. He also advises investors and explains how he sees the industry evolving.
You can visit Optios at www.optios.com.
David can be contacted via email at email@example.com.
Direct download: David_Bach_of_Optios.mp3
Category: -- posted at: 12:04pm CST
Tue, 24 November 2020
Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.
I often see CFOs and board members give the investor pitch instead of the CEO. In an emergency this is okay, but by and large, the CEO should be giving the pitch.
The investors want to size up the CEO and know who is running the business.
I find the CEO stand-ins can deliver the information, but they rarely close the deal.
As a CEO, you need to give the pitch and deliver the vision with a compelling narrative.
You need to know your numbers well and how the business model works.
In short, you need to be able to answer all the questions AND sell it.
You can get help from others to build the financial model and put a good design on the pitch deck.
Team members can also help with identifying investors, developing key metrics, and other support functions.
But ultimately, there’s no one like the CEO to pitch investors as that is what it will take to close the investment.
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Feedback please contact firstname.lastname@example.org
Direct download: Startup_Funding_Espresso_--_The_CEO_Should_Pitch_the_Investor.mp3
Category:general -- posted at: 7:00am CST